Eli Lilly has been making quite a bit of noise thanks to its work in diabetes and obesity. Investors turned on the company, ...

It’s important to help our kids maintain a healthy weight. But sometimes well-intentioned interventions can cause more harm ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...

Pudgy pets are a problem in America. According to the Association for Pet Obesity Prevention, a shocking 56% of dogs and 60% ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Hims stock jumped late Monday after the online pharmacy beat expectations, helped by Hims & Hers' weight-loss drug.

Viking Therapeutics (VKTX) surges on promising obesity drug results. Explore key price levels and analyst insights in this detailed analysis.

Related Text-messaging program helps parents prevent obesity in young children Ozempic ... focused on almost 15,000 adult ...

Patients with asthma who switched biologics multiple times were younger, more likely to identify as Black, and had more ...

The study reveals a dose-response relationship between BMI and PASC risk in children, highlighting obesity as a key factor in post-COVID health challenges.